Active patients—latent patient response difference: (95% CI) | p-Value* | Active patients (TB-HIV)—active patient (TB) response difference: (95% CI) | p-Value* | |
Redness | 31.5% (−10% to 60%) | 0.236 | −21.3% (−40% to 50%) | 1.000 |
Pain | 46.9% (10% to 70%) | 0.033 | −21.3% (−40% to 50%) | 1.000 |
Itchiness | 37.8% (0% to 70%) | 0.033 | 21.2% (−30% to 60%) | 1.000 |
Watery | 55.9% (20% to 80%) | 0.004 | 3.1% (−50% to 40%) | 1.000 |
Light sensitivity | 30.1% (−10% to 60%) | 0.209 | −12.2% (−50% to 40%) | 1.000 |
Visual disturbance | 2.8% (−30% to 30%) | 1.000 | 15.1% (−20% to 30%) | 1.000 |
Loss of vision | 9.1% (−10% to 40%) | 1.000 | −9.1% (−40% to 50%) | 1.000 |
Floaters | 27.3% (0% to 60%) | 0.041 | 39.4% (−20% to 70%) | 1.000 |
↵* Fisher exact significance (two-sided).